GAMMA Investing LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 2010235 FOSTER CITY, CA

Position in NBIX

as of Mar 31, 2026 · filed Apr 6, 2026 Compact

Position Value

$374,932

-$56,798 QoQ

Shares Held

2,846

-6.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GAMMA Investing LLC holds $6,004,464 across 46 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,338	$1,340,264
2	UTHR	UNITED THERAPEUTICS Corp	1,604	$951,139
3	VTRS	Viatris Inc	39,167	$529,146
4	NBIX	Neurocrine Biosciences Inc This page	2,846	$374,932
5	ELAN	Elanco Animal Health Inc	12,998	$311,042
6	HLN	Haleon plc	29,472	$295,014
7	TEVA	Teva Pharmaceutical Industries Ltd	9,502	$286,200
8	LNTH	Lantheus Holdings, Inc.	3,146	$238,624

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$374,932	2,846	-6.5%	Shares	Defined	2026-04-06
2025-12-31	$431,730	3,044	+13.3%	Shares	Defined	2026-01-05
2025-09-30	$377,060	2,686	+14.1%	Shares	Defined	2025-10-02
2025-06-30	$295,999	2,355	+18.9%	Shares	Defined	2025-07-14
2025-03-31	$219,098	1,981	-13.7%	Shares	Defined	2025-04-15
2024-12-31	$313,267	2,295	+32.0%	Shares	Defined	2025-01-03
2024-09-30	$200,252	1,738	+11.9%	Shares	Defined	2024-10-07
2024-06-30	$213,801	1,553	+34.1%	Shares	Defined	2024-07-02
2024-03-31	$159,711	1,158	+36.6%	Shares	Defined	2024-04-05
2023-12-31	$111,732	848	—	Shares	Defined	2024-02-01
No filing history on record for this holder in this stock.